Laboratory Diagnosis of Congenital Toxoplasmosis
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Recent studies have demonstrated that screening and treatment for toxoplasmosis during gestation result in a decrease of vertical transmission and clinical sequelae. Early treatment was associated with improved outcomes. Thus, laboratory methods should aim for early identification of infants with congenital toxoplasmosis (CT). Diagnostic approaches should include, at least, detection of Toxoplasma IgG, IgM, and IgA and a comprehensive review of maternal history, including the gestational age at which the mother was infected and treatment. Here, we review laboratory methods for the diagnosis of CT, with emphasis on serological tools. A diagnostic algorithm that takes into account maternal history is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of congenital toxoplasmosis: a systematic review
Torgerson, P. R., & Mastroiacovo, P. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.111732 · Cited by 748
(2007) · The Lancet · doi:10.1016/s0140-6736(07)60072-5 · Cited by 542
Wolf, A., Cowen, D., & Paige, B. H. (1939) · Science · doi:10.1126/science.89.2306.226 · Cited by 330 · cited 1×
“(1) reported for the first time that the intracellular protozoan parasite Toxoplasma gondii was a pathogen for humans and that it was capable of causing congenital disease as well (1, 2).”
BackgroundWallon, M., Peyron, F., Cornu, C., Vinault, S., Abrahamowicz, M., Kopp, C. B., & Binquet, C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit032 · Cited by 239 · cited 1×
“This strategy has been shown to decrease mother to child transmission and severe disease and death in the offspring (9).”
BackgroundCortina-Borja, M., Tan, H. K., Wallon, M., Paul, M., Prusa, A., Buffolano, W., Malm, G., Salt, A., Freeman, K., Petersen, E., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000351 · Cited by 214
Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment
Moncada, P. A., & Montoya, J. G. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.58 · Cited by 211
Self-citationA plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes
Zhang, B., Kumar, R. B., Dai, H., & Feldman, B. J. (2014) · Nature Medicine · doi:10.1038/nm.3619 · Cited by 176
Remington and Klein's Infectious Diseases of The Fetus and Newborn Infant
Garg, S., & Tin, W. (2015) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2015.09.002 · Cited by 153
The Austrian Toxoplasmosis Register, 1992-2008
Prusa, A. R., Kasper, D. C., Pollak, A. J., Gleiß, A., Waldhoer, T., & Hayde, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu724 · Cited by 105
Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States
Dhakal, R., Gajurel, K., Pomares-Estran, C., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01663-15 · Cited by 96
Cited by
Congenital Toxoplasmosis: The State of the Art
Bollani, L., Auriti, C., Achille, C., Garofoli, F., De Rose, D. U., Meroni, V., Salvatori, G., & Tzialla, C. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.894573 · Cited by 176
“However, after the third month of life, the test becomes non-specific (67).”
Background
Metadata
- Authors
- Pomares, C., & Montoya, J. G.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-10
- Volume
- 54
- Issue
- 10
- Pages
- 2448-2454
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2347192098
- Cited by
- 158
- References
- 15
- FWCI
- 15.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.